<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0177713</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-48889</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Cholesterol</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis B virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis B virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis B virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Metabolic disorders</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Carbohydrate metabolism</subject><subj-group><subject>Glucose metabolism</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Lipid metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Lipid metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Liver diseases</subject><subj-group><subject>Cirrhosis</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis</article-title>
<alt-title alt-title-type="running-head">HBV surface antigen positivity and metabolic syndrome prevalence</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Yuanyuan</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhao</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9363-3848</contrib-id>
<name name-style="western">
<surname>Wu</surname>
<given-names>Jianping</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Department of Laboratory Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Bonino</surname>
<given-names>Ferruccio</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Universita degli Studi di Pisa, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item>
<p><bold>Conceptualization:</bold> YL.</p></list-item> <list-item>
<p><bold>Data curation:</bold> YL YZ.</p></list-item> <list-item>
<p><bold>Formal analysis:</bold> YL YZ.</p></list-item> <list-item>
<p><bold>Funding acquisition:</bold> JW.</p></list-item> <list-item>
<p><bold>Investigation:</bold> YL YZ JW.</p></list-item> <list-item>
<p><bold>Methodology:</bold> YZ.</p></list-item> <list-item>
<p><bold>Project administration:</bold> JW.</p></list-item> <list-item>
<p><bold>Resources:</bold> JW.</p></list-item> <list-item>
<p><bold>Supervision:</bold> JW.</p></list-item> <list-item>
<p><bold>Validation:</bold> YL.</p></list-item> <list-item>
<p><bold>Visualization:</bold> YL.</p></list-item> <list-item>
<p><bold>Writing – original draft:</bold> YL.</p></list-item> <list-item>
<p><bold>Writing – review &amp; editing:</bold> YL YZ JW.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">jpwuzyyy@126.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>5</issue>
<elocation-id>e0177713</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Li et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0177713"/>
<abstract>
<sec id="sec001">
<title>Background and aim</title>
<p>As there is conflicting evidence for the relationship between hepatitis B virus surface antigen (HBsAg) positivity and the prevalence of metabolic syndrome (MetS), we performed a meta-analysis to investigate whether HBsAg positivity affects the incidence of MetS.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>Observational studies on the relationship between HBsAg positivity and MetS were obtained from PubMed, Web of Science, and the Cochrane Library in April 2016. The pooled odds ratios (ORs) of MetS and its components (central obesity, increased fasting glucose, increased blood pressure, dyslipidemia) for subjects with or without HBsAg positivity were synthesized. The standardized mean difference of MetS components between HBsAg-positive participants and healthy controls was calculated. Heterogeneity was explored with subgroup analysis and sensitivity analysis. Publication bias was detected using Egger’s test and Begg’s test.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Thirty studies were eligible for meta-analysis. The MetS OR for HBsAg-positive participants was significantly decreased compared with the controls [OR = 0.80, 95% confidence interval (CI), 0.70–0.90]. The negative effect of HBsAg positivity on elevated triglycerides (OR = 0.62, 95% CI, 0.59–0.64) was strong, while that for increased fasting blood glucose was weak (OR = 0.94, 95% CI, 0.90–0.98). The pooled ORs of central obesity (OR = 0.97, 95% CI, 0.91–1.04), reduced high-density lipoprotein cholesterol (OR = 0.98, 95% CI, 0.83–1.14), and elevated blood pressure (OR = 1.00, 95% CI, 0.80–1.25) for HBsAg-positive participants were all not significantly different compared with the controls. No publication bias was detected.</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>Serum HBsAg positivity is inversely associated with the prevalence of MetS. Among the five components of MetS, elevated triglycerides had the strongest inverse relationship with HBsAg positivity.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>the Medical Science and Technology Project of Zhejiang Province</institution>
</funding-source>
<award-id>2016KYB107</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9363-3848</contrib-id>
<name name-style="western">
<surname>Wu</surname>
<given-names>Jianping</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>Support was provided by the Medical Science and Technology Project of Zhejiang Province (2016KYB107); [<ext-link ext-link-type="uri" xlink:href="http://kj.zjwst.gov.cn/" xlink:type="simple">http://kj.zjwst.gov.cn/</ext-link>]. The funders played roles in decision to publish and preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="5"/>
<page-count count="17"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Chronic hepatitis B virus (HBV) infection remains a globally challenging problem, as it can lead to chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma [<xref ref-type="bibr" rid="pone.0177713.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0177713.ref002">2</xref>]. Metabolic syndrome (MetS), characterized by a cluster of metabolic abnormalities including central obesity, increased fasting blood glucose (FBG), increased blood pressure (BP), and dyslipidemia, is another issue of global concern. MetS is a confirmed risk factor for type 2 diabetes mellitus and atherosclerotic cardiovascular disease [<xref ref-type="bibr" rid="pone.0177713.ref003">3</xref>], and its prevalence has grown rapidly over the past two decades [<xref ref-type="bibr" rid="pone.0177713.ref004">4</xref>].</p>
<p>The liver plays an undeniably important role in lipid and glucose metabolism. MetS involves dyslipidemia and glucose abnormalities. Dyslipidemia is associated with the development of obesity and hypertension, which are also components of MetS. Additionally, nonalcoholic steatohepatitis is considered the hepatic manifestation of MetS [<xref ref-type="bibr" rid="pone.0177713.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0177713.ref006">6</xref>], and MetS and nonalcoholic steatohepatitis are mutual promoters [<xref ref-type="bibr" rid="pone.0177713.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0177713.ref008">8</xref>]. Overall, MetS is related to the liver in some way. The hepatitis virus damages liver function; does it also disrupt the metabolism of lipids and glucose in the liver? Subsequently, does it affect the incidence of MetS?</p>
<p>HBV and hepatitis C virus (HCV) are two common types of hepatitis virus that share some similarities. Chronic HCV infection contributes to MetS, as it induced insulin resistance in a genotype-dependent model [<xref ref-type="bibr" rid="pone.0177713.ref009">9</xref>]. However, the relationship between HBV and MetS in the literature, including large population-based surveys, remains inconclusive. HBV surface antigen (HBsAg) positivity and HBV infection are not synonymous, e.g., there can be occult HBV infection with HBsAg-negative status. Even so, HBsAg positivity is closely related to various HBV infection statuses (HBV carrier, chronic active hepatitis, liver cirrhosis). Consequently, HBsAg is usually an indicator of HBV infection. Some studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>] concluded that HBsAg seropositivity is a protective factor against MetS, while others [<xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>–<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>] have found no association between HBsAg positivity and MetS. These conflicting evidences render a systematic assessment necessary. Unfortunately, the relevant systematic analysis has not been performed. Therefore, we performed this meta-analysis to investigate whether HBsAg seropositivity affects the incidence of MetS and whether HBsAg positivity is related to the components of MetS (central obesity, increased FBG, increased BP, dyslipidemia).</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec007">
<title>Search strategy</title>
<p>This meta-analysis was performed according to a proposal for reporting meta-analysis of observational studies [<xref ref-type="bibr" rid="pone.0177713.ref018">18</xref>]. We searched the following databases without time limitations: PubMed, Web of Science, the Cochrane Library. The search strategy for identifying all relevant literature used the following keywords: hepatitis B, metabolic syndrome, hypertension, hyperglycemia, hypertriglyceridemia, dyslipidemia (see <xref ref-type="supplementary-material" rid="pone.0177713.s007">S1 Text</xref>). The literature search was updated in April 2016.</p>
</sec>
<sec id="sec008">
<title>Study selection</title>
<p>Studies were deemed eligible if they met the following criteria: (1) investigated the association between HBsAg positivity and MetS (including components of MetS: central obesity; increased triglyceride [TG]; reduced high-density lipoprotein cholesterol [HDL-C]; increased BP; increased FBG). HBV infection was defined as HBsAg seropositivity; (2) used healthy subjects as the control group; (3) included &gt;30 subjects with HBsAg positivity; otherwise, a study was excluded for low statistical power and poor reliability. Exclusion criteria were studies on co-infection, such as human immunodeficiency virus and HBV co-infection, liver cirrhosis, hepatocarcinoma, following antiviral therapy, pregnant or pediatric populations.</p>
</sec>
<sec id="sec009">
<title>Methodological quality assessment and data extraction</title>
<p>Two authors (L.Y.Y. and Z.Y.) independently assessed the quality of eligible studies. The Newcastle-Ottawa Scale criteria [<xref ref-type="bibr" rid="pone.0177713.ref019">19</xref>] were recommended by the Cochrane Collaboration for assessing the quality of nonrandomized studies in a meta-analysis. As it was suitable for case-control and cohort studies, we modified it for cross-sectional studies (<xref ref-type="table" rid="pone.0177713.t001">Table 1</xref>). An additional explanation was needed for Q4, which involved the definition of MetS and its components. MetS was defined as the presence of three or more of the following items [<xref ref-type="bibr" rid="pone.0177713.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0177713.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0177713.ref021">21</xref>]: (1) elevated waist circumference (WC) (population- and country-specific definitions); (2) elevated TG (≥150 mg/dL) or therapy; (3) reduced HDL-C (men, &lt;40 mg/dL; women, &lt;50 mg/dL) or therapy; (4) elevated BP (systolic ≥ 130 mmHg and/or diastolic ≥ 85 mmHg) or therapy; (5) elevated FBG or therapy. Elevated FBG was defined slightly differently (≥100 mg/dL [<xref ref-type="bibr" rid="pone.0177713.ref020">20</xref>] and ≥110 mg/dL [<xref ref-type="bibr" rid="pone.0177713.ref021">21</xref>]). Both were allowable in this meta-analysis, and further subgroup analysis was performed. The checklist of Q4 was that “The MetS and its components were defined accurately”. Here, the accurate definition of MetS must meet the above criteria. The accurate definition of a MetS component must match the corresponding item of the MetS component. For example, one study focused only on the relationship between HBsAg positivity and TG (one component of MetS), and the cutoff value for calculating the odds ratio (OR) for elevated TG was identical with the item of MetS (TG ≥ 150 mg/dL). This study was also awarded one star for Q4. Discrepancies during methodological quality assessment were resolved by consensus agreement.</p>
<table-wrap id="pone.0177713.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.t001</object-id>
<label>Table 1</label> <caption><title>Checklist of methodological quality assessment.</title></caption>
<alternatives>
<graphic id="pone.0177713.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify">Code</th>
<th align="justify">Checklist</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">Q1</td>
<td align="justify">The participants were recruited from general population, and were not from hospital;</td>
</tr>
<tr>
<td align="justify">Q2</td>
<td align="justify">The subjects with HBsAg positivity and controls were from the same community;</td>
</tr>
<tr>
<td align="justify">Q3</td>
<td align="justify">The experimental group was composed of subjects with HBsAg positivity;</td>
</tr>
<tr>
<td align="justify">Q4<xref ref-type="table-fn" rid="t001fn002"><sup>†</sup></xref></td>
<td align="justify">The MetS and its components were defined accurately;</td>
</tr>
<tr>
<td align="justify">Q5</td>
<td align="justify">The same detection method was applied to subjects with HBsAg positivity and controls;</td>
</tr>
<tr>
<td align="justify">Q6</td>
<td align="justify">The same diagnostic criteria were applied to define MetS and its components for subjects with HBsAg positivity and controls;</td>
</tr>
<tr>
<td align="justify">Q7</td>
<td align="justify">The studies list inclusion and exclusion criteria, and patients with hepatitis C virus infection should be excluded at least;</td>
</tr>
<tr>
<td align="justify">Q8</td>
<td align="justify">The studies which were included to calculate combined standardized mean difference were matched for age and sex at least. The studies which were included to calculate combined odds ratio were adjusted for age and sex at least;</td>
</tr>
<tr>
<td align="justify">Q9</td>
<td align="justify">The lifestyle (alcohol and smoking at least) should be considered. The confounding factors from lifestyle were not significantly different between subjects with HBsAg positivity and controls; or they were adjusted in calculating odds ratio.</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>MetS, metabolic syndrome; HBsAg, hepatitis B surface antigen;</p></fn>
<fn id="t001fn002"><p><sup>†</sup>, MetS was defined as the presence of three or more of the following items: (1) elevated waist circumference (population- and country-specific definitions); (2) elevated triglycerides (≥150 mg/dL) or therapy; (3) reduced high-density lipoprotein cholesterol (&lt;40 mg/dL in men; &lt;50 mg/dL in women) or therapy; (4) elevated blood pressure (systolic ≥ 130 mmHg and/or diastolic ≥ 85 mm Hg) or therapy; (5) elevated fasting blood glucose (≥100 mg/dL or ≥110 mg/dL) or therapy. The accurate definition of MetS must meet the above criteria. The accurate definition of a MetS component must match the corresponding item of the MetS component. For example, one study focused only on the relationship between HBsAg positivity and TG (one component of MetS), and the cutoff value for calculating the OR for elevated TG was identical with the item of MetS (TG ≥ 150 mg/dL). This study was also awarded one star for Q4.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>For continuous variables, the mean and standard deviation (SD) of WC, body mass index (BMI), TG, HDL-C, FBG, systolic BP, and diastolic BP for HBsAg positive subjects and the controls were extracted. For categorical variables, the adjusted OR was extracted; otherwise, the crude data were extracted to calculate the OR. In addition, the datasheet included the publication year, region, study design, source of subjects, sample size, mean age, gender distribution, and diagnostic criteria of MetS.</p>
</sec>
<sec id="sec010">
<title>Statistical analysis</title>
<p>The standardized mean difference (SMD) of WC, BMI, TG, HDL-C, FBG, systolic BP, and diastolic BP between the HBsAg-positive group and controls was calculated. Then, the pooled SMD and associated 95% confidence intervals (CI) were obtained from a DerSimonian and Laird random effects model [<xref ref-type="bibr" rid="pone.0177713.ref022">22</xref>]. More importantly, pooled OR was selected to assess the relationship between HBsAg positivity and MetS. Heterogeneity between eligible studies was evaluated by the I<sup>2</sup> test. The degree of heterogeneity was classified to three levels (minimal, I<sup>2</sup> &lt; 25%; moderate, 25% ≤ I<sup>2</sup> &lt; 50%; substantial, I<sup>2</sup> ≥ 50%) [<xref ref-type="bibr" rid="pone.0177713.ref023">23</xref>]. If no significant heterogeneity was detected (<italic>P</italic> &gt; 0.05 and I<sup>2</sup> &lt; 50%), the fixed effect model was used to calculate the pooled OR and 95% CI. Otherwise, the random effect model was used. To investigate the source of heterogeneity, subgroup analysis and sensitivity analysis was performed according to the factors related to quality assessment. Publication bias was assessed with Egger’s test [<xref ref-type="bibr" rid="pone.0177713.ref024">24</xref>] and Begg’s test [<xref ref-type="bibr" rid="pone.0177713.ref025">25</xref>] (significance at <italic>P</italic> &lt; 0.05). Statistical analyses were conducted with Review Manager 5.3 (The Cochrane Collaboration) and STATA 11.0 (Stata Corp., College Station, TX, USA).</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>Study characteristics</title>
<p>We retrieved 2687 studies using the described search strategies. We excluded 2657 studies in accordance with our inclusion and exclusion criteria (<xref ref-type="fig" rid="pone.0177713.g001">Fig 1</xref>). Ultimately, 30 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] were eligible for this meta-analysis. <xref ref-type="table" rid="pone.0177713.t002">Table 2</xref> lists their general characteristics. There were 139,167,581 subjects in total, and most of the studies were from the Asia-Pacific region. The sample sizes of the 30 studies varied from 73 [<xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>] to 138,877,499 participants [<xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>], but the majority of studies (n = 25) enrolled &gt;500 subjects. The participants’ average age ranged 33–61 years. Ten studies [<xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0177713.ref041">41</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] only reported MetS components in the form of continuous variables, and they mainly affected the pooled SMD of MetS components. Consequently, we did not consider in our analysis the MetS criteria they used. In other words, whether these studies [<xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0177713.ref041">41</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] meet the MetS criteria (Q4: The MetS and its components were defined accurately) did not affect the statistical results (SMD), so they were labeled with “UR” (unrelated) for Q4 in <xref ref-type="table" rid="pone.0177713.t003">Table 3</xref>. The remaining 20 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0177713.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref043">43</xref>] reported ORs or crude data for calculating the ORs. The MetS criteria used in these 20 studies was similar, but not identical. <xref ref-type="supplementary-material" rid="pone.0177713.s006">S1 Table</xref> lists the detailed criteria applied in these 20 studies.</p>
<table-wrap id="pone.0177713.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.t002</object-id>
<label>Table 2</label> <caption><title>Characteristics of the studies included in the meta-analysis.</title></caption>
<alternatives>
<graphic id="pone.0177713.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Author, year</th>
<th align="justify">Region</th>
<th align="center">Study design</th>
<th align="center">General population</th>
<th align="center">Age<xref ref-type="table-fn" rid="t002fn003"><sup>‡</sup></xref></th>
<th align="left">HBsAg (+)<break/>(male%)<xref ref-type="table-fn" rid="t002fn006"><sup>£</sup></xref></th>
<th align="left">HBsAg (-)<break/>(male%)<xref ref-type="table-fn" rid="t002fn006"><sup>£</sup></xref></th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">Huang CY, 2016 [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">36.2±3.8 <italic>vs</italic>. 36.1±3.9</td>
<td align="justify">2982 (54.4)</td>
<td align="justify">14048 (41.4)</td>
</tr>
<tr>
<td align="justify">Katoonizadeh A, 2016 [<xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>]</td>
<td align="justify">Iran</td>
<td align="justify">Unclear</td>
<td align="justify">Yes</td>
<td align="justify">56.1±8.3 <italic>vs</italic>. 56.0±8.0</td>
<td align="justify">2249 (52.4)</td>
<td align="justify">10532 (47.0)</td>
</tr>
<tr>
<td align="justify">Fan JY, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref027">27</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">49.8±16.4</td>
<td align="justify">1265 (50.1)</td>
<td align="justify">5540 (42.1)</td>
</tr>
<tr>
<td align="justify">Ha M, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>]</td>
<td align="justify">China</td>
<td align="justify">cross section</td>
<td align="justify">Patients</td>
<td align="justify">40±13 <italic>vs</italic>. 44±15</td>
<td align="justify">121 (54.5)</td>
<td align="justify">263 (56.3)</td>
</tr>
<tr>
<td align="justify">Hsu CS, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">51.8±9.6 <italic>vs</italic>. 51±12.9</td>
<td align="justify">187 (56.7)</td>
<td align="justify">184 (54.4)</td>
</tr>
<tr>
<td align="justify">Choi JS, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>]</td>
<td align="justify">Korea</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">47.1±15.1</td>
<td align="justify">209 (51.2)</td>
<td align="justify">4899 (41.6)</td>
</tr>
<tr>
<td align="justify">Park B, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref029">29</xref>]</td>
<td align="justify">Korea</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">&gt;30</td>
<td align="justify">916 (48.3)</td>
<td align="justify">23355</td>
</tr>
<tr>
<td align="justify">Jinjuvadia R, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>]</td>
<td align="justify">US</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">&gt;18</td>
<td align="justify">593594 (68.1)</td>
<td align="justify">138283905 (47.5)</td>
</tr>
<tr>
<td align="justify">Jarčuška P, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>]</td>
<td align="justify">Slovakia</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">33.8±6.9 <italic>vs</italic>. 34.1 ± 8.4</td>
<td align="justify">66</td>
<td align="justify">771</td>
</tr>
<tr>
<td align="justify" rowspan="2">Chung TH, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>]</td>
<td align="justify" rowspan="2">Korea</td>
<td align="justify" rowspan="2">cross section</td>
<td align="justify" rowspan="2">Yes</td>
<td align="justify">45.7±5.7 <italic>vs</italic>. 50.0±6.0(m)<xref ref-type="table-fn" rid="t002fn004"><sup>§</sup></xref></td>
<td align="justify" rowspan="2">521 (83.9)</td>
<td align="justify" rowspan="2">8953 (80.0)</td>
</tr>
<tr>
<td align="justify">45.4±9.4 <italic>vs</italic>. 47±9.9(f)</td>
</tr>
<tr>
<td align="justify">Liu PT, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">47±11</td>
<td align="justify">1036 (64.1)</td>
<td align="justify">6659 (56.6)</td>
</tr>
<tr>
<td align="justify">Li WC, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref032">32</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">40.7±13.2</td>
<td align="justify">3408 (62.4)</td>
<td align="justify">22897 (54.2)</td>
</tr>
<tr>
<td align="justify">Wong VWS, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>]</td>
<td align="justify">Hong Kong</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">49±10 <italic>vs</italic>. 48±11</td>
<td align="justify">91</td>
<td align="justify">922</td>
</tr>
<tr>
<td align="justify">Hsu CS 2012 [<xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Patients</td>
<td align="justify">unclear</td>
<td align="justify">322 (53.1)</td>
<td align="justify">870 (53.7)</td>
</tr>
<tr>
<td align="justify">Chen JY, 2010 [<xref ref-type="bibr" rid="pone.0177713.ref035">35</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">60.9±11.8</td>
<td align="justify">6133</td>
<td align="justify">50203</td>
</tr>
<tr>
<td align="justify">Ishizaka N, 2008 [<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>]</td>
<td align="justify">Japan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">55.3±10.6 <italic>vs</italic>. 53.1±10.6</td>
<td align="justify">130 (71.5)</td>
<td align="justify">12333 (64.2)</td>
</tr>
<tr>
<td align="justify">Yang KC, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">48.0±9.6 <italic>vs</italic>. 48.4±10.7</td>
<td align="justify">87 (72.4)</td>
<td align="justify">421 (76.48)</td>
</tr>
<tr>
<td align="justify">Luo B, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref013">13</xref>]</td>
<td align="justify">China</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">43.5 (32–87)</td>
<td align="justify">858 (75.8)</td>
<td align="justify">6579 (64.6)</td>
</tr>
<tr>
<td align="justify">Lin YC, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref043">43</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">45.9±8.8 <italic>vs</italic>. 46.3±9.5</td>
<td align="justify">817 (59.9)</td>
<td align="justify">4589 (49.5)</td>
</tr>
<tr>
<td align="justify">Jan CF, 2006 [<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>]</td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">30–79</td>
<td align="justify">5994</td>
<td align="justify">41699</td>
</tr>
<tr>
<td align="justify">Chiang CH, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">33.0±8.6 <italic>vs</italic>. 23.5±2.4</td>
<td align="justify">147 (76.9)</td>
<td align="justify">359 (63.0)</td>
</tr>
<tr>
<td align="justify">Cheng YL, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>] <xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">49.5±11.5 <italic>vs</italic>. 52.2±13.3</td>
<td align="justify">3642 (59.3)</td>
<td align="justify">29797 (54.4)</td>
</tr>
<tr>
<td align="justify">Lee JG, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref038">38</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">South Korea</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">48.9±10(m); 48.6±10(f) <xref ref-type="table-fn" rid="t002fn005"><sup>¶</sup></xref></td>
<td align="center" colspan="2">7880 (48.9)</td>
</tr>
<tr>
<td align="justify">Karsen H, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Turkey</td>
<td align="justify">cross section</td>
<td align="justify">Unclear</td>
<td align="justify">36.2±14.2 <italic>vs</italic>. 35.2±14.1</td>
<td align="justify">34 (47.1)</td>
<td align="justify">39 (43.6)</td>
</tr>
<tr>
<td align="justify">Dai F, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref040">40</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">China</td>
<td align="justify">cross section</td>
<td align="justify">Patients</td>
<td align="justify">38.7±9.5 <italic>vs</italic>. 37.2±10.6</td>
<td align="justify">68 (69.1)</td>
<td align="justify">67 (59.7)</td>
</tr>
<tr>
<td align="justify">Huang ZS, 2010 [<xref ref-type="bibr" rid="pone.0177713.ref041">41</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">52.7±0.7 <italic>vs</italic>. 55.1±0.3</td>
<td align="justify">143 (79.0)</td>
<td align="justify">1090 (72.5)</td>
</tr>
<tr>
<td align="justify">Wang CC, 2008 [<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">44.6±1.4 <italic>vs</italic>. 46.8±0.4</td>
<td align="justify">50 (60)</td>
<td align="justify">457 (46.6)</td>
</tr>
<tr>
<td align="justify">Targher G, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref045">45</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Italy</td>
<td align="justify">cross section</td>
<td align="justify">Patients</td>
<td align="justify">47 ± 3 <italic>vs</italic>. 46 ± 3</td>
<td align="justify">35 (65.7)</td>
<td align="justify">60 (68.0)</td>
</tr>
<tr>
<td align="justify">Moritani M, 2005 [<xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Japan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">48.3±1.3 <italic>vs</italic>. 49.3±0.2</td>
<td align="justify">39 (89.7)</td>
<td align="justify">1736 (65.3)</td>
</tr>
<tr>
<td align="justify">Su TC, 2004 [<xref ref-type="bibr" rid="pone.0177713.ref046">46</xref>]<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">Taiwan</td>
<td align="justify">cross section</td>
<td align="justify">Yes</td>
<td align="justify">40.4±7.5 <italic>vs</italic>. 41.1±8.3</td>
<td align="justify">195 (36.9)</td>
<td align="justify">1135 (29.3)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>HBsAg, hepatitis B surface antigen.</p></fn>
<fn id="t002fn002"><p><sup>†</sup> These studies only reported components of MetS in the form of continuous variables.</p></fn>
<fn id="t002fn003"><p><sup>‡</sup> Age was usually expressed as “HBsAg-positive group” vs. “control group” or the overall age distribution including HBsAg-positive and control group.</p></fn>
<fn id="t002fn004"><p><sup>§</sup> “age of HBsAg-positive group” vs. “age of control group” in male subgroup (m) and female subgroup (f), respectively.</p></fn>
<fn id="t002fn005"><p><sup>¶</sup> Overall age distribution in male subgroup (m) and female subgroup (f), respectively.</p></fn>
<fn id="t002fn006"><p><sup>£</sup> Data in parentheses are the percentage of males.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0177713.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.t003</object-id>
<label>Table 3</label> <caption><title>Methodological quality of eligible studies.</title></caption>
<alternatives>
<graphic id="pone.0177713.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Author, year</th>
<th align="justify">Q1</th>
<th align="justify">Q2</th>
<th align="justify">Q3</th>
<th align="justify">Q4</th>
<th align="justify">Q5</th>
<th align="justify">Q6</th>
<th align="justify">Q7</th>
<th align="justify">Q8</th>
<th align="justify">Q9</th>
<th align="justify">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">Huang CY, 2016 [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">9</td>
</tr>
<tr>
<td align="justify">Katoonizadeh A, 2016 [<xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">9</td>
</tr>
<tr>
<td align="justify">Fan JY, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref027">27</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">5</td>
</tr>
<tr>
<td align="justify">Ha M, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>]</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Hsu CS, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Choi JS, 2015 [<xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UC</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Park B, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref029">29</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">6</td>
</tr>
<tr>
<td align="justify">Jinjuvadia R, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">9</td>
</tr>
<tr>
<td align="justify">Jarčuška P, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Chung TH, 2014 [<xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UC</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Liu PT, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">9</td>
</tr>
<tr>
<td align="justify">Li WC, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref032">32</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">6</td>
</tr>
<tr>
<td align="justify">Wong VWS, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">9</td>
</tr>
<tr>
<td align="justify">Hsu CS, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>]</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Chen JY, 2010 [<xref ref-type="bibr" rid="pone.0177713.ref035">35</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">6</td>
</tr>
<tr>
<td align="justify">Ishizaka N, 2008 [<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Yang KC, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">6</td>
</tr>
<tr>
<td align="justify">Luo B, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref013">13</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">6</td>
</tr>
<tr>
<td align="justify">Lin YC, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref043">43</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UC</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">5</td>
</tr>
<tr>
<td align="justify">Jan CF, 2006 [<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">6</td>
</tr>
<tr>
<td align="justify">Chiang CH, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>]</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Cheng YL, 2013 [<xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Lee JG, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref038">38</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Karsen H, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>]</td>
<td align="justify">UC</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Dai F, 2012 [<xref ref-type="bibr" rid="pone.0177713.ref040">40</xref>]</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Huang ZS, 2010 [<xref ref-type="bibr" rid="pone.0177713.ref041">41</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Wang CC, 2008 [<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Targher G, 2007 [<xref ref-type="bibr" rid="pone.0177713.ref045">45</xref>]</td>
<td align="justify">no</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Moritani M, 2005 [<xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">9</td>
</tr>
<tr>
<td align="justify">Su TC, 2004 [<xref ref-type="bibr" rid="pone.0177713.ref046">46</xref>]</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">UR</td>
<td align="justify">yes</td>
<td align="justify">yes</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">no</td>
<td align="justify">6</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>UC: unclear;</p></fn>
<fn id="t003fn002"><p>UR: unrelated. The last 10 studies [<xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0177713.ref041">41</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] in the table reported only metabolic syndrome (MetS) components in the form of continuous variables, and they mainly affected the pooled standardized mean difference (SMD) of the MetS components. SMD was not related to the diagnostic criteria of MetS. Whether these studies [<xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0177713.ref041">41</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] meet Q4 (Q4: MetS and its components were defined accurately) did not affect the statistical results (SMD), so they were labeled “UR” for Q4. The first 20 studies in the table reported OR or crude data for calculating the OR, and the MetS criteria they used affected the statistical results (pooled ORs) directly. Therefore, these studies were carefully investigated to confirm whether they met Q4 (Q4: MetS and its components were defined accurately).</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="pone.0177713.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram of screened, excluded, and analyzed literature.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec013">
<title>Methodological quality assessment</title>
<p><xref ref-type="table" rid="pone.0177713.t003">Table 3</xref> lists the methodological quality of the studies; the average score of all 30 studies was 7.23. Five studies [<xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0177713.ref040">40</xref>, <xref ref-type="bibr" rid="pone.0177713.ref045">45</xref>] did not collect information on HBsAg-positive subjects from the general population, but from patients in the infection department. One study [<xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>] enrolled university graduates as the healthy controls, who were much younger than the HBsAg-positive group. One study [<xref ref-type="bibr" rid="pone.0177713.ref043">43</xref>] did not define the HBsAg-positive group explicitly. The definition criteria of MetS differed slightly in these studies even though most of them were based on National Cholesterol Education Program Adult Treatment Expert Panel III (ATP III) [<xref ref-type="bibr" rid="pone.0177713.ref021">21</xref>] (<xref ref-type="supplementary-material" rid="pone.0177713.s006">S1 Table</xref>). Five studies involved the distinctive definition of MetS or its components. Jarčuška <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>] considered that MetS must present with central obesity. Increased BP was defined as systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg in three studies [<xref ref-type="bibr" rid="pone.0177713.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0177713.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>] and as systolic BP ≥ 135 mmHg or diastolic BP ≥ 90 mmHg in one study [<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>]. The Q7, Q8, and Q9 checklists were mainly used to control confounders. Ten studies involved the confounding of HCV. Eleven studies did not control for confounding of age and sex well, while 20 studies did not control for confounding of lifestyle well.</p>
</sec>
<sec id="sec014">
<title>HBsAg positivity and MetS</title>
<p>Twelve studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>] reported the OR for HBsAg positivity and prevalence of MetS. In all, 610,021 HBsAg-positive subjects and 138,407,811 healthy controls were enrolled in the meta-analysis. The pooled OR for HBsAg positivity and MetS prevalence was 0.80 (95% CI, 0.70–0.90, I<sup>2</sup> = 72%, <italic>P</italic> &lt; 0.01) (<xref ref-type="fig" rid="pone.0177713.g002">Fig 2</xref>), indicating an inverse association between HBsAg positivity and MetS prevalence. <xref ref-type="table" rid="pone.0177713.t004">Table 4</xref> lists the subgroup analysis results. The inverse relationship was robust in all but the female subgroup. In the general population, the pooled OR from 11 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>] was 0.81 (95% CI, 0.72–0.92, I<sup>2</sup> = 72%, <italic>P</italic> &lt; 0.01). The pooled OR from nine studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>] that rigorously defined MetS with ATP III was 0.80 (95% CI, 0.68–0.94, I<sup>2</sup> = 77%, <italic>P</italic> &lt; 0.01). After excluding the confounder of HCV, the pooled OR was 0.70 (95% CI, 0.53–0.91, I<sup>2</sup> = 80%, <italic>P</italic> &lt; 0.01). The pooled OR from data adjusted for confounders was 0.73 (95% CI, 0.61–0.88, I<sup>2</sup> = 63%, <italic>P</italic> = 0.02). This inverse association was also found in the male subgroup (OR = 0.85; 95% CI, 0.74–0.98; I<sup>2</sup> = 64%, <italic>P</italic> = 0.01), but not in the female subgroup (OR = 0.91; 95% CI, 0.74–1.11; I<sup>2</sup> = 66%, <italic>P</italic> = 0.008). Furthermore, the heterogeneity did not decrease through subgroup analysis, therefore the specific factor leading to heterogeneity was not found.</p>
<table-wrap id="pone.0177713.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.t004</object-id>
<label>Table 4</label> <caption><title>Results of subgroup analysis according to quality assessments.</title></caption>
<alternatives>
<graphic id="pone.0177713.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Groups<xref ref-type="table-fn" rid="t004fn002"><sup>†</sup></xref></th>
<th align="left">MetS</th>
<th align="left">Elevated WC</th>
<th align="left">Elevated TG</th>
<th align="left">Reduced HDL-C</th>
<th align="left">Elevated BP</th>
<th align="left">Elevated FBG</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">All</td>
<td align="left">0.80 (0.70–0.90)<xref ref-type="table-fn" rid="t004fn003"><sup>‡</sup></xref>; I<sup>2</sup> = 72%, <italic>P</italic>&lt;0.01; n = 12</td>
<td align="left">0.97 (0.91–1.04); I<sup>2</sup> = 50%, <italic>P</italic> = 0.03; n = 11</td>
<td align="left">0.62 (0.59–0.64); I<sup>2</sup> = 0%, P = 0.52; n = 14<xref ref-type="table-fn" rid="t004fn004"><sup>§</sup></xref></td>
<td align="left">0.98 (0.83–1.14); I<sup>2</sup> = 85%, <italic>P</italic>&lt;0.01; n = 13<xref ref-type="table-fn" rid="t004fn004"><sup>§</sup></xref></td>
<td align="left">1.00 (0.80–1.25); I<sup>2</sup> = 95%, <italic>P</italic>&lt;0.01; n = 11<xref ref-type="table-fn" rid="t004fn004"><sup>§</sup></xref></td>
<td align="left">0.94 (0.90–0.98); I<sup>2</sup> = 21%, <italic>P</italic> = 0.23; n = 13<xref ref-type="table-fn" rid="t004fn004"><sup>§</sup></xref></td>
</tr>
<tr>
<td align="left">Male</td>
<td align="left">0.85 (0.74–0.98); I<sup>2</sup> = 64%, <italic>P</italic> = 0.01; n = 6</td>
<td align="left">0.91 (0.81–1.02); I<sup>2</sup> = 51%, <italic>P</italic> = 0.11; n = 4</td>
<td align="left">--</td>
<td align="left">1.21 (1.05–1.40); I<sup>2</sup> = 50%, <italic>P</italic> = 0.11; n = 4</td>
<td align="left">0.97 (0.80–1.17); I<sup>2</sup> = 5%, <italic>P</italic> = 0.35; n = 3</td>
<td align="left">0.63 (0.39–1.00); I<sup>2</sup> = 89%, <italic>P</italic>&lt;0.01; n = 4</td>
</tr>
<tr>
<td align="left">Female</td>
<td align="left">0.91 (0.74–1.11); I<sup>2</sup> = 66%, <italic>P</italic> = 0.008; n = 6</td>
<td align="left">0.95 (0.84–1.09); I<sup>2</sup> = 0%, <italic>P</italic> = 0.41; n = 4</td>
<td align="left">--</td>
<td align="left">0.82 (0.50–1.35); I<sup>2</sup> = 82%, <italic>P</italic> = 0.009; n = 4</td>
<td align="left">0.95 (0.66–1.39); I<sup>2</sup> = 0, <italic>P</italic> = 0.89; n = 3</td>
<td align="left">1.00 (0.88–1.14); I<sup>2</sup> = 0, <italic>P</italic> = 0.80; n = 4</td>
</tr>
<tr>
<td align="left">Q1 (general population)</td>
<td align="left">0.81 (0.72–0.92); I<sup>2</sup> = 72%, <italic>P</italic>&lt;0.01; n = 11</td>
<td align="left">0.97 (0.91–1.04); I<sup>2</sup> = 55%, <italic>P</italic> = 0.02; n = 10</td>
<td align="left">--</td>
<td align="left">0.95 (0.83–1.09); I<sup>2</sup> = 78%, <italic>P</italic>&lt;0.01; n = 11</td>
<td align="left">0.91 (0.87–0.96); I<sup>2</sup> = 0, <italic>P</italic> = 0.63; n = 9</td>
<td align="left">0.94 (0.90–0.99); I<sup>2</sup> = 27%, <italic>P</italic> = 0.18; n = 11</td>
</tr>
<tr>
<td align="left">Q4 (accurate diagnosis)</td>
<td align="left">0.80 (0.68–0.94); I<sup>2</sup> = 77%, <italic>P</italic>&lt;0.01; n = 9</td>
<td align="left">0.99 (0.94–1.05); I<sup>2</sup> = 0%, <italic>P</italic> = 0.93; n = 6</td>
<td align="left">--</td>
<td align="left">0.98 (0.82–1.16); I<sup>2</sup> = 86%, <italic>P</italic>&lt;0.01; n = 12</td>
<td align="left">0.95 (0.88–1.02); I<sup>2</sup> = 0, <italic>P</italic> = 0.63; n = 7</td>
<td align="left">0.93 (0.87–0.99); I<sup>2</sup> = 1%, <italic>P</italic> = 0.42; n = 7</td>
</tr>
<tr>
<td align="left">Q7 (included and excluded criterion)</td>
<td align="left">0.70 (0.53–0.91); I<sup>2</sup> = 80%, <italic>P</italic>&lt;0.01; n = 7</td>
<td align="left">0.93 (0.83–1.04); I<sup>2</sup> = 61%, <italic>P</italic> = 0.02; n = 7</td>
<td align="left">--</td>
<td align="left">0.94 (0.72–1.21); I<sup>2</sup> = 89%, <italic>P</italic>&lt;0.01; n = 9</td>
<td align="left">0.92 (0.85–1.00); I<sup>2</sup> = 0, <italic>P</italic> = 0.68; n = 6</td>
<td align="left">0.96 (0.91–1.03); I<sup>2</sup> = 37%, <italic>P</italic> = 0.14; n = 7</td>
</tr>
<tr>
<td align="left">Q8 and Q9 (control confounding factors)</td>
<td align="left">0.73(0.61–0.88); I<sup>2</sup> = 63%, <italic>P</italic> = 0.02; n = 6</td>
<td align="left">0.99 (0.91–1.08); I<sup>2</sup> = 64%, <italic>P</italic> = 0.04; n = 4</td>
<td align="left">--</td>
<td align="left">0.88 (0.83–0.94); I<sup>2</sup> = 0%, <italic>P</italic> = 0.47; n = 6</td>
<td align="left">0.90 (0.85–0.94); I<sup>2</sup> = 0, <italic>P</italic> = 0.69; n = 4</td>
<td align="left">0.97 (0.90–1.03); I<sup>2</sup> = 57%, <italic>P</italic> = 0.08; n = 4</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>MetS, metabolic syndrome; WC, waist circumference; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; BP, blood pressure; FBG, fasting blood glucose.</p></fn>
<fn id="t004fn002"><p><sup>†</sup> Grouped according to checklist of quality assessment (Tables <xref ref-type="table" rid="pone.0177713.t001">1</xref> and <xref ref-type="table" rid="pone.0177713.t003">3</xref>).</p></fn>
<fn id="t004fn003"><p><sup>‡</sup> The data in each grid are the OR (95% CI of OR); the parameters of heterogeneity (I<sup>2</sup>, <italic>P</italic>-value); the number of included studies.</p></fn>
<fn id="t004fn004"><p><sup>§</sup> The studies included for calculating the pooled OR here were not identical to those for calculating the pooled SMD.</p></fn>
<fn id="t004fn005"><p>For “Elevated TG”, the pooled OR was from 14 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>–<xref ref-type="bibr" rid="pone.0177713.ref035">35</xref>], and the SMD was from 14 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>]. They are not identical.</p></fn>
<fn id="t004fn006"><p>Similarly, for “Reduced HDL-C”, the pooled OR was from 13 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>], and the SMD was from 19 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>–<xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>–<xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>–<xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>].</p></fn>
<fn id="t004fn007"><p>For “Elevated BP”, the pooled OR was from 11 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>]; the SMD of systolic BP was from 10 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>, <xref ref-type="bibr" rid="pone.0177713.ref045">45</xref>], and the SMD of diastolic BP was from nine studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref045">45</xref>].</p></fn>
<fn id="t004fn008"><p>For “Elevated FBG”, the pooled OR was from 13 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0177713.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>], and the SMD was from 16 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177713.ref040">40</xref>–<xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>].</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="pone.0177713.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plot of the prevalence of MetS in HBsAg-positive subjects versus healthy controls.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec015">
<title>HBsAg positivity and central obesity</title>
<p>WC and BMI are two common indices for assessing central obesity. Eleven studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref043">43</xref>] involving 606,706 HBsAg-positive subjects and 138,369,865 healthy controls reported the OR for HBsAg positivity and increased WC. The pooled OR was 0.97 (95% CI, 0.91–1.04; I<sup>2</sup> = 50%, <italic>P</italic> = 0.03) (<xref ref-type="supplementary-material" rid="pone.0177713.s002">S1 Fig</xref>), indicating that HBsAg positivity was neither a risk factor nor a protective factor for increased WC, and further subgroup analysis grouped according to quality assessment confirmed this. The pooled OR from six studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref043">43</xref>] that defined central obesity as WC &gt; 90 cm in men or &gt;80 cm in women was 0.99 (95% CI, 0.94–1.05; I<sup>2</sup> = 0%, <italic>P</italic> = 0.93). The heterogeneity also decreased in subgroups stratified by sex; the conclusion was identical to the total pooled OR (<xref ref-type="table" rid="pone.0177713.t004">Table 4</xref>). Additionally, six studies [<xref ref-type="bibr" rid="pone.0177713.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0177713.ref043">43</xref>] reported the OR of BMI, and the pooled OR was 0.99 (95% CI, 0.95–1.04; I<sup>2</sup> = 0%, <italic>P</italic> = 0.65), which was consistent with WC.</p>
</sec>
<sec id="sec016">
<title>HBsAg positivity and elevated TG</title>
<p>Fourteen studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>–<xref ref-type="bibr" rid="pone.0177713.ref035">35</xref>] involving 614,363 HBsAg-positive subjects and 138,430,492 healthy controls reported the OR for HBsAg positivity and increased circulating TG levels. The total OR of these 14 studies was 0.62 (95% CI, 0.59–0.64; I<sup>2</sup> = 0%, <italic>P</italic> = 0.52) (<xref ref-type="fig" rid="pone.0177713.g003">Fig 3</xref>), indicating that HBsAg positivity is inversely associated with elevated TG. The heterogeneity among the included studies was so low that the subsequent subgroup analysis was omitted. The SMD of the 14 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] was -0.39 (95% CI, -0.59 to -0.18; I<sup>2</sup> = 98%, <italic>P</italic> &lt; 0.001), indicating that the HBsAg-positive subjects had lower TG than the healthy controls. Although the OR and SMD were calculated from different studies, they revealed a consistent trend.</p>
<fig id="pone.0177713.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plot of the prevalence of elevated TG in HBsAg-positive subjects versus healthy controls.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>HBsAg positivity and reduced HDL-C</title>
<p>Thirteen studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>] involving 605,924 HBsAg-positive subjects and 138,363,354 healthy controls reported the OR for HBsAg positivity and reduced HDL-C. The total OR of the 13 studies was 0.98 (95% CI, 0.83–1.14, I<sup>2</sup> = 85%, <italic>P</italic> &lt; 0.01) (see <xref ref-type="supplementary-material" rid="pone.0177713.s003">S2 Fig</xref>), indicating that HBsAg positivity was not associated with reduced HDL-C. However, the pooled OR of six studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>] that controlled the confounding factors revealed an inverse relationship between HBsAg positivity and reduced HDL-C (OR = 0.88; 95% CI, 0.83–0.94; I<sup>2</sup> = 0%, <italic>P</italic> = 0.47). The dramatic decrease in heterogeneity was due to adjusting for confounding factors (age, sex at least). However, the dramatic decrease in heterogeneity rendered the results more reliable, the inverse relationship was still weak.</p>
</sec>
<sec id="sec018">
<title>HBsAg positivity and elevated BP</title>
<p>Eleven studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>] reported the OR for HBsAg positivity and elevated BP, and only two [<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>] reported that HBsAg positivity was associated with increased BP. The pooled OR of all 11 studies was 1.00 (95% CI, 0.80–1.25; I<sup>2</sup> = 95%, <italic>P</italic> &lt; 0.001) (see <xref ref-type="supplementary-material" rid="pone.0177713.s004">S3 Fig</xref>). After excluding the two studies [<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>], the heterogeneity decreased significantly, and the combined OR from the remaining nine studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>] was 0.94 (95% CI, 0.88–1.01, I<sup>2</sup> = 0%, <italic>P</italic> = 0.76). The subgroup that included seven studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0177713.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>] based on ATP III (systolic BP ≥ 130 mmHg or diastolic BP ≥ 85 mmHg) also showed no relationship between HBsAg positivity and increased BP (OR = 0.95; 95% CI, 0.88–1.02; I<sup>2</sup> = 0%, <italic>P</italic> = 0.63). Additionally, similar trends were found in the SMD of systolic BP and diastolic BP. In conclusion, HBsAg positivity was neither a risk factor nor a protective factor for increased BP, and the difference in BP between HBsAg-positive subjects and healthy controls was not significant.</p>
</sec>
<sec id="sec019">
<title>HBsAg positivity and elevated FBG</title>
<p>Thirteen studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0177713.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>] reported the OR for HBsAg positivity and elevated FBG. The total OR of these 13 studies, which involved 610,127 HBsAg-positive subjects and 138,408,194 controls, was 0.94 (95% CI, 0.90–0.98; I<sup>2</sup> = 21%, <italic>P</italic> = 0.23) (see <xref ref-type="supplementary-material" rid="pone.0177713.s005">S4 Fig</xref>), indicating that HBsAg positivity is inversely associated with increased FBG, but this inverse relationship was not robust in the subsequent subgroup analysis (<xref ref-type="table" rid="pone.0177713.t004">Table 4</xref>). Seven studies [<xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0177713.ref029">29</xref>–<xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>] defined elevated FBG as ≥100 mg/dL, and the pooled OR was 0.93 (95% CI, 0.87–0.99; I<sup>2</sup> = 1%, <italic>P</italic> = 0.42). Six studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0177713.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0177713.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0177713.ref028">28</xref>] defined elevated FBG as ≥110 mg/dL, and the pooled OR was 0.95 (95% CI, 0.89–1.01; I<sup>2</sup> = 45%, <italic>P</italic> = 0.11). The SMD derived from 16 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177713.ref040">40</xref>–<xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] was 0.03 (95% CI, -0.21 to 0.27; I<sup>2</sup> = 99%, <italic>P</italic> &lt; 0.0001). Overall, the effect of HBsAg positivity on glucose homeostasis appeared slight. However, further research is required to confirm this.</p>
</sec>
<sec id="sec020">
<title>Publication bias</title>
<p>Publication bias was not detected by Egger’s test or Begg’s test (<xref ref-type="table" rid="pone.0177713.t005">Table 5</xref>). For Egger’s test, the publication bias 95% CI of each group included zero and <italic>P</italic> &gt; 0.05, so there was no statistical difference between publication bias and zero, meaning no publication bias was present; Begg’s test derived the same conclusion. Taken together, this indicates that there was no publication bias in our meta-analysis.</p>
<table-wrap id="pone.0177713.t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177713.t005</object-id>
<label>Table 5</label> <caption><title>Analysis of publication bias of the included studies.</title></caption>
<alternatives>
<graphic id="pone.0177713.t005g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.t005" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify" rowspan="2">Group</th>
<th align="justify" rowspan="2">Studies</th>
<th align="left" rowspan="2">Begg’s test (<italic>P</italic>-value)</th>
<th align="center" colspan="2">Egger’s test</th>
</tr>
<tr>
<th align="justify"><italic>P</italic>-value</th>
<th align="justify">95% CI of bias</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">MetS</td>
<td align="justify">12</td>
<td align="char" char=".">0.086</td>
<td align="char" char=".">0.089</td>
<td align="justify">-3.34 to 0.28</td>
</tr>
<tr>
<td align="justify">Elevated BMI</td>
<td align="justify">6</td>
<td align="char" char=".">0.707</td>
<td align="char" char=".">0.300</td>
<td align="justify">-0.88 to 2.21</td>
</tr>
<tr>
<td align="justify">Elevated WC</td>
<td align="justify">11</td>
<td align="char" char=".">0.119</td>
<td align="char" char=".">0.506</td>
<td align="justify">-2.03 to 1.08</td>
</tr>
<tr>
<td align="justify">Elevated TG</td>
<td align="justify">14</td>
<td align="char" char=".">0.274</td>
<td align="char" char=".">0.228</td>
<td align="justify">-1.37 to 0. 36</td>
</tr>
<tr>
<td align="justify">Reduced HDL-C</td>
<td align="justify">13</td>
<td align="char" char=".">0.583</td>
<td align="char" char=".">0.866</td>
<td align="justify">-3.01 to 2.57</td>
</tr>
<tr>
<td align="justify">Elevated BP</td>
<td align="justify">11</td>
<td align="char" char=".">1.000</td>
<td align="char" char=".">0.902</td>
<td align="justify">-5.66 to 5.06</td>
</tr>
<tr>
<td align="justify">Elevated FBG</td>
<td align="justify">13</td>
<td align="char" char=".">0.161</td>
<td align="char" char=".">0.123</td>
<td align="justify">-2.09 to 0.29</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t005fn001"><p>MetS, metabolic syndrome; BMI, body mass index; WC, waist circumference; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; BP, blood pressure; FBG, fasting blood glucose.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Discussion</title>
<p>In this meta-analysis, HBsAg-positive individuals had lower prevalence of MetS. This negative association remained robust after adjustment for confounding factors (e.g., age, sex). Meanwhile, a strong inverse relationship was demonstrated between HBsAg positivity and elevated TG (one component of MetS). There was a slight effect of HBsAg positivity on glucose homeostasis. The total OR of all eligible studies indicated no association between HBsAg positivity and reduced HDL-C, but OR controlled for the confounding factors revealed a slight inverse relationship. Additionally, it was confirmed that HBsAg positivity is not associated with central obesity and increased BP. Overall, we speculate that HBsAg positivity protects against the incidence of MetS mainly due to its negative effect on elevated TG. Naturally, further research is required to confirm this.</p>
<p>There was a negative association between HBsAg positivity and the prevalence of MetS, and HBsAg positivity is closely related to HBV. HBV may prevent the occurrence of MetS instead of promoting it. That is, HBV may protect humans against MetS. HBV is considered a “metabolovirus”, as it adopts a regulatory system that is unique to the major hepatic metabolic genes that control hepatic glucose and lipid metabolism [<xref ref-type="bibr" rid="pone.0177713.ref048">48</xref>]. HBV infection alters bile acid and cholesterol metabolism as a consequence of impaired bile acid uptake [<xref ref-type="bibr" rid="pone.0177713.ref048">48</xref>]. Besides, HBV X protein induces the transcriptional activation of peroxisome proliferator–activated receptor γ (PPARγ) [<xref ref-type="bibr" rid="pone.0177713.ref049">49</xref>]. The activation of PPARγ gene expression during HBV replication boosts the increase in circulating adiponectin levels [<xref ref-type="bibr" rid="pone.0177713.ref050">50</xref>, <xref ref-type="bibr" rid="pone.0177713.ref051">51</xref>]. Adiponectin has anti-inflammatory effects and protects against insulin resistance. It is inversely associated with BMI, type 2 diabetes mellitus, and several metabolic disorders [<xref ref-type="bibr" rid="pone.0177713.ref051">51</xref>, <xref ref-type="bibr" rid="pone.0177713.ref052">52</xref>]. Additionally, nonalcoholic steatohepatitis is considered the hepatic manifestation of MetS. A meta-analysis and several large-cohort studies have proven that HBV has a protective effect against the development of hepatic steatosis [<xref ref-type="bibr" rid="pone.0177713.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0177713.ref053">53</xref>]. The evidence described above all support the inverse relationship between HBsAg positivity and the prevalence of MetS; however, prospective studies are warranted to elucidate the exact mechanism and to validate the inverse relationship.</p>
<p>A recent review [<xref ref-type="bibr" rid="pone.0177713.ref006">6</xref>] has also shown an inverse relationship between HBV and increased TG. The liver is the main organ for lipid metabolism, and hepatic dysfunction such as inflammation, liver fibrosis, cirrhosis, and hepatocellular carcinoma may occur during HBV infection. These processes all influence lipid biosynthesis and metabolism and relate to the change in TG levels [<xref ref-type="bibr" rid="pone.0177713.ref035">35</xref>]. Kim <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0177713.ref049">49</xref>] reported that HBV X protein inhibits the secretion of apolipoprotein B. Apolipoprotein B in the liver is an important glycoprotein for the transport of TG-rich very low–density lipoprotein cholesterol and low-density lipoprotein cholesterol. Therefore, HBV X protein increases rapidly upon the active replication of HBV. Then, it inhibits very low–density lipoprotein cholesterol and low-density lipoprotein cholesterol production and promotes TG accumulation in hepatocytes, decreasing TG in the blood. Additionally, increased levels of adiponectin caused by HBV replication reduce serum TG levels and increase HDL-C levels [<xref ref-type="bibr" rid="pone.0177713.ref054">54</xref>]. Besides TG, accumulating evidence has revealed that chronic HBV infection is also inversely associated with other lipid profiles, including cholesterol and low-density lipoprotein cholesterol [<xref ref-type="bibr" rid="pone.0177713.ref006">6</xref>], and we found a similar trend. In our study, the OR for increased cholesterol from four studies [<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0177713.ref035">35</xref>] was 0.76 (95%CI, 0.65–0.89), and the SMD from 13 studies [<xref ref-type="bibr" rid="pone.0177713.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0177713.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177713.ref040">40</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref044">44</xref>, <xref ref-type="bibr" rid="pone.0177713.ref046">46</xref>, <xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] was -1.24 (95%CI, -1.64 to -0.84). The SMD of low-density lipoprotein cholesterol from 10 studies [<xref ref-type="bibr" rid="pone.0177713.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0177713.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177713.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177713.ref037">37</xref>–<xref ref-type="bibr" rid="pone.0177713.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0177713.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0177713.ref045">45</xref>–<xref ref-type="bibr" rid="pone.0177713.ref047">47</xref>] was -0.43 (95%CI, -0.69 to -0.16). The pooled OR of six studies that controlled the confounding factors revealed a slight inverse relationship between HBsAg positivity and reduced HDL-C. In fact, there was interaction between HBV infection and lipid metabolism. Moderate-severe hepatic steatosis may contribute to HBsAg seroclearance due to steatosis-induced apoptosis and inflammation [<xref ref-type="bibr" rid="pone.0177713.ref055">55</xref>]. In short, the possible mechanism for HBsAg positivity with lower TG levels could be related to viral factors and host factors. Furthermore, the weak inverse relationship between HBsAg positivity and reduced HDL-C should be confirmed via further investigation.</p>
<p>The inverse relationship between HBsAg positivity and increased FBG was statistically significant, but was weak in the clinic. The relationship between HBV and insulin resistance remains inconclusive and awaits further studies for clarification [<xref ref-type="bibr" rid="pone.0177713.ref006">6</xref>]. However, it is worth pointing out that cirrhosis and poor glycemic control are closely associated [<xref ref-type="bibr" rid="pone.0177713.ref056">56</xref>, <xref ref-type="bibr" rid="pone.0177713.ref057">57</xref>]. It has been speculated that peripheral insulin clearance is reduced because of cirrhosis, and then insulin resistance and glucose abnormalities occur secondary to hyperinsulinemia [<xref ref-type="bibr" rid="pone.0177713.ref058">58</xref>].</p>
<p>To the best of our knowledge, this is the first meta-analysis to investigate the relationship between HBsAg positivity and MetS (including its components). Additionally, this meta-analysis was performed rigorously according to a proposal for reporting meta-analysis of observational studies [<xref ref-type="bibr" rid="pone.0177713.ref018">18</xref>]. Although Wang <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0177713.ref006">6</xref>] also focused on the association between HBV infection and MetS, theirs was more of an excellent review than a meta-analysis. Second, most of the included studies enrolled &gt;500 subjects, and the large sample size made the conclusion more credible.</p>
<p>There are several limitations to the present meta-analysis. First, the majority of eligible studies were cross-sectional studies, which always demonstrate the least evidence among the three types of observational studies (case-control, cohort, cross-sectional). Additionally, time is an important factor that should be considered, as HBsAg-positive individuals may have different outcomes. Unfortunately, it was difficult to assess the impact of time in this meta-analysis, which we attribute to the cross-sectional nature of the included studies. Second, because only HBsAg was tested and/or it was tested for only once in most of the eligible studies, various conditions related to HBsAg were not taken into account. An HBsAg-positive individual may be a healthy carrier, a patient with chronic active hepatitis, or a patient with liver cirrhosis. Although most studies focused on the general population and most HBsAg-positive subjects may be HBV carriers in this meta-analysis, further stratification of HBsAg status is still needed to assess the exact role of HBsAg in the development of MetS in the future. Third, both age and gender play an important role in the natural history of chronic HBV infection. Unfortunately, the studies included in the subgroup analysis based on these two factors were very limited; however, the negative association between HBsAg passivity and MetS remained robust after adjustment for confounding factors (e.g., age, sex). Fourth, with respect to the definition of MetS, we were not concerned whether drug treatment was an alternate indicator. Finally, we were unsuccessful in obtaining supplemental information from several authors; however, no publication bias was detected.</p>
<p>Our meta-analysis has several implications for future research. First, a prospective large-cohort study is needed to validate our conclusion. In this regard, the Newcastle–Ottawa Scale [<xref ref-type="bibr" rid="pone.0177713.ref019">19</xref>] describes the requirements for a rigorous study design and methodology and is a good tool for guiding study design. The unified definition of MetS [<xref ref-type="bibr" rid="pone.0177713.ref004">4</xref>] should be used. As described above, some important factors, such as time, age, gender, and various conditions related to HBsAg, should be taken into account thoroughly in future research. On the other hand, the physiopathological mechanism of the inverse association between HBsAg positivity and MetS requires further research.</p>
<p>In conclusion, serum HBsAg positivity is inversely associated with MetS. Among the five components of MetS, elevated triglycerides had the strongest inverse relationship with HBsAg positivity.</p>
</sec>
<sec id="sec022">
<title>Supporting information</title>
<supplementary-material id="pone.0177713.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.s001" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177713.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.s002" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Meta-analysis of the prevalence of elevated WC in HBsAg positivity versus healthy control (forest plot).</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177713.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.s003" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Meta-analysis of the prevalence of reduced HDL-C in HBsAg positivity versus healthy control (forest plot).</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177713.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.s004" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Meta-analysis of the prevalence of elevated BP in HBsAg positivity versus healthy control (forest plot).</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177713.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.s005" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Meta-analysis of the prevalence of elevated FBG in HBsAg positivity versus healthy control (forest plot).</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177713.s006" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.s006" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Diagnostic criteria of MetS and its components in the included studies.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177713.s007" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0177713.s007" xlink:type="simple">
<label>S1 Text</label>
<caption>
<title>The electronic search strategy for PubMed database.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Elixigen Corporation (Huntington Beach, California, USA) for helping in proofreading and editing the English of final manuscript.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>ATP III</term>
<def><p>National Cholesterol Education Program Adult Treatment Expert Panel III</p></def>
</def-item>
<def-item><term>BMI</term>
<def><p>body mass index</p></def>
</def-item>
<def-item><term>BP</term>
<def><p>blood pressure</p></def>
</def-item>
<def-item><term>Cl</term>
<def><p>confidence interval</p></def>
</def-item>
<def-item><term>FBG</term>
<def><p>fasting blood glucose</p></def>
</def-item>
<def-item><term>HBsAg</term>
<def><p>hepatitis B virus surface antigen</p></def>
</def-item>
<def-item><term>HBV</term>
<def><p>hepatitis B virus</p></def>
</def-item>
<def-item><term>HCV</term>
<def><p>hepatitis C virus</p></def>
</def-item>
<def-item><term>HDL-C</term>
<def><p>high-density lipoprotein cholesterol</p></def>
</def-item>
<def-item><term>MetS</term>
<def><p>metabolic syndrome</p></def>
</def-item>
<def-item><term>OR</term>
<def><p>odds ratio</p></def>
</def-item>
<def-item><term>PPARγ</term>
<def><p>peroxisome proliferator–activated receptor γ</p></def>
</def-item>
<def-item><term>SD</term>
<def><p>standard deviation</p></def>
</def-item>
<def-item><term>SMD</term>
<def><p>standardized mean difference</p></def>
</def-item>
<def-item><term>TG</term>
<def><p>triglyceride</p></def>
</def-item>
<def-item><term>WC</term>
<def><p>waist circumference</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pone.0177713.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Locarnini</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hatzakis</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Lok</surname> <given-names>A</given-names></name>. <article-title>Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs</article-title>. <source>J Hepatol</source>. <year>2015</year>;<volume>62</volume>(<issue>1S</issue>):<fpage>S76</fpage>–<lpage>S86</lpage>.</mixed-citation></ref>
<ref id="pone.0177713.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ganem</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Prince</surname> <given-names>AM</given-names></name>. <article-title>Hepatitis B virus infection--natural history and clinical consequences</article-title>. <source>N Engl J Med</source>. <year>2004</year>;<volume>350</volume>(<issue>11</issue>):<fpage>1118</fpage>–<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMra031087" xlink:type="simple">10.1056/NEJMra031087</ext-link></comment> <object-id pub-id-type="pmid">15014185</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grundy</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Hansen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>SC</given-names> <suffix>Jr.</suffix></name>, <name name-style="western"><surname>Cleeman</surname> <given-names>JI</given-names></name>, <name name-style="western"><surname>Kahn</surname> <given-names>RA</given-names></name>. <article-title>Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management</article-title>. <source>Circulation</source>. <year>2004</year>;<volume>109</volume>(<issue>4</issue>):<fpage>551</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/01.CIR.0000112379.88385.67" xlink:type="simple">10.1161/01.CIR.0000112379.88385.67</ext-link></comment> <object-id pub-id-type="pmid">14757684</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eckel</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Alberti</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Grundy</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Zimmet</surname> <given-names>PZ</given-names></name>. <article-title>The metabolic syndrome</article-title>. <source>Lancet</source>. <year>2010</year>;<volume>375</volume>(<issue>9710</issue>):<fpage>181</fpage>–<lpage>3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(09)61794-3" xlink:type="simple">10.1016/S0140-6736(09)61794-3</ext-link></comment> <object-id pub-id-type="pmid">20109902</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Patton</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Yates</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Unalp-Arida</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Behling</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>TT</given-names></name>, <name name-style="western"><surname>Rosenthal</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease</article-title>. <source>Am J Gastroenterol</source>. <year>2010</year>;<volume>105</volume>(<issue>9</issue>):<fpage>2093</fpage>–<lpage>102</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ajg.2010.152" xlink:type="simple">10.1038/ajg.2010.152</ext-link></comment> <object-id pub-id-type="pmid">20372110</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Tseng</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Kao</surname> <given-names>JH</given-names></name>. <article-title>Hepatitis B virus infection and metabolic syndrome: fact or fiction?</article-title> <source>J Gastroenterol Hepatol</source>. <year>2015</year>;<volume>30</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/jgh.12700" xlink:type="simple">10.1111/jgh.12700</ext-link></comment> <object-id pub-id-type="pmid">25092429</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marchesini</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bugianesi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Forlani</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Cerrelli</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Lenzi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Manini</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome</article-title>. <source>Hepatology</source>. <year>2003</year>;<volume>37</volume>(<issue>4</issue>):<fpage>917</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1053/jhep.2003.50161" xlink:type="simple">10.1053/jhep.2003.50161</ext-link></comment> <object-id pub-id-type="pmid">12668987</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Hung</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>HH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>LT</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>KC</given-names></name>. <article-title>Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>:<fpage>27034</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep27034" xlink:type="simple">10.1038/srep27034</ext-link></comment> <object-id pub-id-type="pmid">27246655</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sheikh</surname> <given-names>MY</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Qadri</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Friedman</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Sanyal</surname> <given-names>AJ</given-names></name>. <article-title>Hepatitis C virus infection: molecular pathways to metabolic syndrome</article-title>. <source>Hepatology</source>. <year>2008</year>;<volume>47</volume>(<issue>6</issue>):<fpage>2127</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.22269" xlink:type="simple">10.1002/hep.22269</ext-link></comment> <object-id pub-id-type="pmid">18446789</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Chiang</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>LT</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>KC</given-names></name>. <article-title>Relationship between chronic hepatitis B and metabolic syndrome: A structural equation modeling approach</article-title>. <source>Obesity (Silver Spring)</source>. <year>2016</year>;<volume>24</volume>(<issue>2</issue>):<fpage>483</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="pone.0177713.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ha</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Xia</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Shen</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients</article-title>. <source>Obes Res Clin Pract</source>. <year>2015</year>.</mixed-citation></ref>
<ref id="pone.0177713.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jinjuvadia</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Liangpunsakul</surname> <given-names>S</given-names></name>. <article-title>Association between metabolic syndrome and its individual components with viral hepatitis B</article-title>. <source>Am J Med Sci</source>. <year>2014</year>;<volume>347</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MAJ.0b013e31828b25a5" xlink:type="simple">10.1097/MAJ.0b013e31828b25a5</ext-link></comment> <object-id pub-id-type="pmid">23514672</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Luo</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>K</given-names></name>. <article-title>Association of metabolic syndrome and hepatitis B infection in a Chinese population</article-title>. <source>Clin Chim Acta</source>. <year>2007</year>;<volume>380</volume>(<issue>1–2</issue>):<fpage>238</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cca.2007.01.012" xlink:type="simple">10.1016/j.cca.2007.01.012</ext-link></comment> <object-id pub-id-type="pmid">17316590</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jan</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Chiu</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10)</article-title>. <source>Int J Obes (Lond)</source>. <year>2006</year>;<volume>30</volume>(<issue>5</issue>):<fpage>794</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="pone.0177713.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Katoonizadeh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ghoroghi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sharafkhah</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Khoshnia</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mirzaei</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Shayanrad</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome</article-title>. <source>J Med Virol</source>. <year>2016</year>;<volume>88</volume>(<issue>7</issue>):<fpage>1230</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jmv.24466" xlink:type="simple">10.1002/jmv.24466</ext-link></comment> <object-id pub-id-type="pmid">26742819</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jarcuska</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Janicko</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kruzliak</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Novak</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Veseliny</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Fedacko</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis B virus infection in patients with metabolic syndrome: A complicated relationship. Results of a population based study</article-title>. <source>Eur J Intern Med</source>. <year>2014</year>;<volume>25</volume>(<issue>3</issue>):<fpage>286</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejim.2014.01.006" xlink:type="simple">10.1016/j.ejim.2014.01.006</ext-link></comment> <object-id pub-id-type="pmid">24445023</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ishizaka</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ishizaka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Seki</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Nagai</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yamakado</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Koike</surname> <given-names>K</given-names></name>. <article-title>Association between hepatitis B/C viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening</article-title>. <source>Hepatol Res</source>. <year>2008</year>;<volume>38</volume>(<issue>8</issue>):<fpage>775</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1872-034X.2008.00334.x" xlink:type="simple">10.1111/j.1872-034X.2008.00334.x</ext-link></comment> <object-id pub-id-type="pmid">18371161</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stroup</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Berlin</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Morton</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Olkin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Williamson</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Rennie</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group</article-title>. <source>JAMA</source>. <year>2000</year>;<volume>283</volume>(<issue>15</issue>):<fpage>2008</fpage>–<lpage>12</lpage>. <object-id pub-id-type="pmid">10789670</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref019"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Wells; G, Shea; B, O'Connell; D, Peterson; J, Welch; V, Losos; M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [WWW document] URL <ext-link ext-link-type="uri" xlink:href="http://wwwohrica/programs/clinical_epidemiology/oxfordhtm" xlink:type="simple">http://wwwohrica/programs/clinical_epidemiology/oxfordhtm</ext-link>. (accessed May 12, 2014).</mixed-citation></ref>
<ref id="pone.0177713.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alberti</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Eckel</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Grundy</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Zimmet</surname> <given-names>PZ</given-names></name>, <name name-style="western"><surname>Cleeman</surname> <given-names>JI</given-names></name>, <name name-style="western"><surname>Donato</surname> <given-names>KA</given-names></name>, <etal>et al</etal>. <article-title>Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity</article-title>. <source>Circulation</source>. <year>2009</year>;<volume>120</volume>(<issue>16</issue>):<fpage>1640</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192644" xlink:type="simple">10.1161/CIRCULATIONAHA.109.192644</ext-link></comment> <object-id pub-id-type="pmid">19805654</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>25</issue>):<fpage>3143</fpage>–<lpage>421</lpage>. <object-id pub-id-type="pmid">12485966</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>. <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source>. <year>1986</year>;<volume>7</volume>(<issue>3</issue>):<fpage>177</fpage>–<lpage>88</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source>. <year>2003</year>;<volume>327</volume>(<issue>7414</issue>):<fpage>557</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.327.7414.557" xlink:type="simple">10.1136/bmj.327.7414.557</ext-link></comment> <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>–<lpage>34</lpage>. Epub 1997/10/06. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>;<volume>50</volume>(<issue>4</issue>):<fpage>1088</fpage>–<lpage>101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Chao</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>HH</given-names></name>, <name name-style="western"><surname>Tseng</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection</article-title>. <source>Hepatol Int</source>. <year>2015</year>;<volume>9</volume>(<issue>2</issue>):<fpage>231</fpage>–<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12072-015-9616-2" xlink:type="simple">10.1007/s12072-015-9616-2</ext-link></comment> <object-id pub-id-type="pmid">25788201</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fan</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Jane</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>MY</given-names></name>. <article-title>Prevention of Liver Cancer Through the Early Detection of Risk-related Behavior Among Hepatitis B or C Carriers</article-title>. <source>Cancer Nurs</source>. <year>2015</year>;<volume>38</volume>(<issue>3</issue>):<fpage>169</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/NCC.0000000000000153" xlink:type="simple">10.1097/NCC.0000000000000153</ext-link></comment> <object-id pub-id-type="pmid">24836958</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Chun</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HC</given-names></name>, <etal>et al</etal>. <article-title>Serum HBV Surface Antigen Positivity is Associated With Low Prevalence of Metabolic Syndrome in Korean Adult Men</article-title>. <source>J Epidemiol</source>. <year>2015</year>;<volume>25</volume>(<issue>1</issue>):<fpage>74</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2188/jea.JE20140053" xlink:type="simple">10.2188/jea.JE20140053</ext-link></comment> <object-id pub-id-type="pmid">25283312</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Suh</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jun</surname> <given-names>JK</given-names></name>. <article-title>Prevalence of and factors influencing impaired glucose tolerance among hepatitis B carriers: a nationwide cross-sectional study in the Republic of Korea</article-title>. <source>Medicine (Baltimore)</source>. <year>2014</year>;<volume>93</volume>(<issue>20</issue>):<fpage>e91</fpage>.</mixed-citation></ref>
<ref id="pone.0177713.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chung</surname> <given-names>TH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>CS</given-names></name>. <article-title>Association between Hepatitis B Surface Antigen Seropositivity and Metabolic Syndrome</article-title>. <source>Korean J Fam Med</source>. <year>2014</year>;<volume>35</volume>(<issue>2</issue>):<fpage>81</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4082/kjfm.2014.35.2.81" xlink:type="simple">10.4082/kjfm.2014.35.2.81</ext-link></comment> <object-id pub-id-type="pmid">24724003</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>JD</given-names></name>. <article-title>Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia</article-title>. <source>Metabolism</source>. <year>2013</year>;<volume>62</volume>(<issue>2</issue>):<fpage>220</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.metabol.2012.07.022" xlink:type="simple">10.1016/j.metabol.2012.07.022</ext-link></comment> <object-id pub-id-type="pmid">22938729</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>YY</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>IC</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Chiu</surname> <given-names>FH</given-names></name>, <name name-style="western"><surname>Chuang</surname> <given-names>CH</given-names></name>. <article-title>Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age</article-title>. <source>Liver Int</source>. <year>2013</year>;<volume>33</volume>(<issue>8</issue>):<fpage>1194</fpage>–<lpage>202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/liv.12224" xlink:type="simple">10.1111/liv.12224</ext-link></comment> <object-id pub-id-type="pmid">23782533</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname> <given-names>VW</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>GL</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Chim</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Ong</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Yeung</surname> <given-names>DK</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis B virus infection and fatty liver in the general population</article-title>. <source>J Hepatol</source>. <year>2012</year>;<volume>56</volume>(<issue>3</issue>):<fpage>533</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jhep.2011.09.013" xlink:type="simple">10.1016/j.jhep.2011.09.013</ext-link></comment> <object-id pub-id-type="pmid">22027575</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Tseng</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>CL</given-names></name>, <etal>et al</etal>. <article-title>Impact of hepatitis B virus infection on metabolic profiles and modifying factors</article-title>. <source>J Viral Hepat</source>. <year>2012</year>;<volume>19</volume>(<issue>2</issue>):<fpage>e48</fpage>–<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2893.2011.01535.x" xlink:type="simple">10.1111/j.1365-2893.2011.01535.x</ext-link></comment> <object-id pub-id-type="pmid">22239526</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>PF</given-names></name>, <name name-style="western"><surname>Tseng</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>CH</given-names></name>, <etal>et al</etal>. <article-title>Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2010</year>;<volume>25</volume>(<issue>11</issue>):<fpage>1763</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1440-1746.2010.06300.x" xlink:type="simple">10.1111/j.1440-1746.2010.06300.x</ext-link></comment> <object-id pub-id-type="pmid">21039839</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chiang</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Hung</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>LT</given-names></name>, <name name-style="western"><surname>Sheu</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>KC</given-names></name>. <article-title>Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers</article-title>. <source>Obesity (Silver Spring)</source>. <year>2013</year>;<volume>21</volume>(<issue>2</issue>):<fpage>291</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0177713.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Kao</surname> <given-names>WY</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>Huo</surname> <given-names>Tl</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>YH</given-names></name>, <etal>et al</etal>. <article-title>Inverse Association between Hepatitis B Virus Infection and Fatty Liver Disease: A Large-Scale Study in Populations Seeking for Check-Up</article-title>. <source>Plos One</source>. <year>2013</year>;<volume>8</volume>(<issue>8</issue>).</mixed-citation></ref>
<ref id="pone.0177713.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HH</given-names></name>, <etal>et al</etal>. <article-title>Association of chronic viral hepatitis B with insulin resistance</article-title>. <source>World J Gastroenterol</source>. <year>2012</year>;<volume>18</volume>(<issue>42</issue>):<fpage>6120</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3748/wjg.v18.i42.6120" xlink:type="simple">10.3748/wjg.v18.i42.6120</ext-link></comment> <object-id pub-id-type="pmid">23155341</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karsen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Binici</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Sunnetcioglu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Baran</surname> <given-names>AI</given-names></name>, <name name-style="western"><surname>Ceylan</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Selek</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B</article-title>. <source>Afr Health Sci</source>. <year>2012</year>;<volume>12</volume>(<issue>2</issue>):<fpage>114</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4314/ahs.v12i2.6" xlink:type="simple">10.4314/ahs.v12i2.6</ext-link></comment> <object-id pub-id-type="pmid">23056015</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dai</surname> <given-names>FH</given-names></name>, <name name-style="western"><surname>Zeng</surname> <given-names>WQ</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>CY</given-names></name>. <article-title>Assessment of the factors associated with insulin resistance in patients with chronic hepatitis B infection</article-title>. <source>Zhonghua Gan Zang Bing Za Zhi</source>. <year>2012</year>;<volume>20</volume>(<issue>7</issue>):<fpage>517</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3760/cma.j.issn.1007-3418.2012.07.008" xlink:type="simple">10.3760/cma.j.issn.1007-3418.2012.07.008</ext-link></comment> <object-id pub-id-type="pmid">23044237</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>ZS</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>TH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Kao</surname> <given-names>JH</given-names></name>. <article-title>Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2010</year>;<volume>25</volume>(<issue>8</issue>):<fpage>1420</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1440-1746.2010.06268.x" xlink:type="simple">10.1111/j.1440-1746.2010.06268.x</ext-link></comment> <object-id pub-id-type="pmid">20659233</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Su</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Jeng</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>LY</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese</article-title>. <source>Atherosclerosis</source>. <year>2007</year>;<volume>195</volume>(<issue>2</issue>):<fpage>392</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.atherosclerosis.2006.10.018" xlink:type="simple">10.1016/j.atherosclerosis.2006.10.018</ext-link></comment> <object-id pub-id-type="pmid">17134707</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Hsiao</surname> <given-names>ST</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>JD</given-names></name>. <article-title>Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults</article-title>. <source>World J Gastroenterol</source>. <year>2007</year>;<volume>13</volume>(<issue>12</issue>):<fpage>1805</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3748/wjg.v13.i12.1805" xlink:type="simple">10.3748/wjg.v13.i12.1805</ext-link></comment> <object-id pub-id-type="pmid">17465470</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moritani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Adachi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Arima</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Takashima</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Miyaoka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Niigaki</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A study of arteriosclerosis in healthy subjects with HBV and HCV infection</article-title>. <source>J Gastroenterol</source>. <year>2005</year>;<volume>40</volume>(<issue>11</issue>):<fpage>1049</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00535-005-1655-3" xlink:type="simple">10.1007/s00535-005-1655-3</ext-link></comment> <object-id pub-id-type="pmid">16322949</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Targher</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bertolini</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Padovani</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Rodella</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Arcaro</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Day</surname> <given-names>C</given-names></name>. <article-title>Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C</article-title>. <source>J Hepatol</source>. <year>2007</year>;<volume>46</volume>(<issue>6</issue>):<fpage>1126</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jhep.2007.01.021" xlink:type="simple">10.1016/j.jhep.2007.01.021</ext-link></comment> <object-id pub-id-type="pmid">17335930</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Su</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>YT</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Chien</surname> <given-names>HP</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>JD</given-names></name>. <article-title>Chronic hepatitis B virus infection and dyslipidemia</article-title>. <source>J Formos Med Assoc</source>. <year>2004</year>;<volume>103</volume>(<issue>4</issue>):<fpage>286</fpage>–<lpage>91</lpage>. <object-id pub-id-type="pmid">15175824</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Kao</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>DS</given-names></name>. <article-title>Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2008</year>;<volume>23</volume>(<issue>5</issue>):<fpage>779</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1440-1746.2007.05216.x" xlink:type="simple">10.1111/j.1440-1746.2007.05216.x</ext-link></comment> <object-id pub-id-type="pmid">18028349</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shlomai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Shaul</surname> <given-names>Y</given-names></name>. <article-title>The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon</article-title>. <source>Med Hypotheses</source>. <year>2008</year>;<volume>71</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.mehy.2007.08.032" xlink:type="simple">10.1016/j.mehy.2007.08.032</ext-link></comment> <object-id pub-id-type="pmid">18334285</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Shin</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Rhee</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Moon</surname> <given-names>HB</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma</article-title>. <source>Gastroenterology</source>. <year>2007</year>;<volume>132</volume>(<issue>5</issue>):<fpage>1955</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1053/j.gastro.2007.03.039" xlink:type="simple">10.1053/j.gastro.2007.03.039</ext-link></comment> <object-id pub-id-type="pmid">17484888</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chiang</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>KC</given-names></name>. <article-title>Association between metabolic factors and chronic hepatitis B virus infection</article-title>. <source>World J Gastroenterol</source>. <year>2014</year>;<volume>20</volume>(<issue>23</issue>):<fpage>7213</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3748/wjg.v20.i23.7213" xlink:type="simple">10.3748/wjg.v20.i23.7213</ext-link></comment> <object-id pub-id-type="pmid">24966591</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname> <given-names>VW</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>GL</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>HY</given-names></name>, <etal>et al</etal>. <article-title>Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese</article-title>. <source>Am J Gastroenterol</source>. <year>2010</year>;<volume>105</volume>(<issue>1</issue>):<fpage>132</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ajg.2009.560" xlink:type="simple">10.1038/ajg.2009.560</ext-link></comment> <object-id pub-id-type="pmid">19809411</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McManus</surname> <given-names>DD</given-names></name>, <name name-style="western"><surname>Lyass</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ingelsson</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Massaro</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Meigs</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Aragam</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study</article-title>. <source>Obesity (Silver Spring)</source>. <year>2012</year>;<volume>20</volume>(<issue>9</issue>):<fpage>1882</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0177713.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Machado</surname> <given-names>MV</given-names></name>, <name name-style="western"><surname>Oliveira</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Cortez-Pinto</surname> <given-names>H</given-names></name>. <article-title>Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2011</year>;<volume>26</volume>(<issue>9</issue>):<fpage>1361</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1440-1746.2011.06801.x" xlink:type="simple">10.1111/j.1440-1746.2011.06801.x</ext-link></comment> <object-id pub-id-type="pmid">21649726</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qiao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zou</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>van der Westhuyzen</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Shao</surname> <given-names>J</given-names></name>. <article-title>Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism</article-title>. <source>Diabetes</source>. <year>2008</year>;<volume>57</volume>(<issue>7</issue>):<fpage>1824</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/db07-0435" xlink:type="simple">10.2337/db07-0435</ext-link></comment> <object-id pub-id-type="pmid">18375436</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>DY</given-names></name>, <name name-style="western"><surname>Liaw</surname> <given-names>YF</given-names></name>. <article-title>Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?</article-title> <source>Int J Obes (Lond)</source>. <year>2007</year>;<volume>31</volume>(<issue>5</issue>):<fpage>871</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="pone.0177713.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsieh</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Hsieh</surname> <given-names>YJ</given-names></name>. <article-title>Impact of liver diseases on the development of type 2 diabetes mellitus</article-title>. <source>World J Gastroenterol</source>. <year>2011</year>;<volume>17</volume>(<issue>48</issue>):<fpage>5240</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3748/wjg.v17.i48.5240" xlink:type="simple">10.3748/wjg.v17.i48.5240</ext-link></comment> <object-id pub-id-type="pmid">22219592</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holstein</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hinze</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Thiessen</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Plaschke</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Egberts</surname> <given-names>EH</given-names></name>. <article-title>Clinical implications of hepatogenous diabetes in liver cirrhosis</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2002</year>;<volume>17</volume>(<issue>6</issue>):<fpage>677</fpage>–<lpage>81</lpage>. <object-id pub-id-type="pmid">12100613</object-id></mixed-citation></ref>
<ref id="pone.0177713.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ahmadieh</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Azar</surname> <given-names>ST</given-names></name>. <article-title>Liver disease and diabetes: association, pathophysiology, and management</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2014</year>;<volume>104</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.diabres.2014.01.003" xlink:type="simple">10.1016/j.diabres.2014.01.003</ext-link></comment> <object-id pub-id-type="pmid">24485856</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>